Tixagevimab
Tixagevimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Tixagevimab is under investigation in clinical trial NCT04625972 (Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults).
| Trade Name | Tixagevimab |
| Generic | Tixagevimab |
| Tixagevimab Other Names | Tixagevimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Tixagevimab
